Somatostatin analogs in acromegaly

[1] The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (04) : 415 - 421

[2] Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) : 527 - 532

[3] Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg) [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) : 4099 - 4103

[4] PREOPERATIVE TREATMENT OF ACROMEGALY WITH LONG-ACTING SOMATOSTATIN ANALOG SMS-201-995 - SHRINKAGE OF INVASIVE PITUITARY MACROADENOMAS AND IMPROVED SURGICAL REMISSION RATE [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (05) : 1040 - 1048

[5] TREATMENT OF RESISTANT ACROMEGALY WITH A LONG-ACTING SOMATOSTATIN ANALOG (SMS 201-995) [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (06) : 856 - 861

[6] DOES TREATMENT OF ACROMEGALY AFFECT LIFE EXPECTANCY [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (01): : 1 - 5

[7] BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X

[8] Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) : 3551 - 3555

[9] RADIOIMMUNOASSAY FOR INSULIN-LIKE GROWTH FACTOR-I - SOLUTIONS TO SOME POTENTIAL PROBLEMS AND PITFALLS [J]. JOURNAL OF ENDOCRINOLOGY, 1991, 128 (03) : 347 - 357

[10] Results of a two-year treatment with slow release lanreotide in acromegaly [J]. HORMONE AND METABOLIC RESEARCH, 2000, 32 (06) : 224 - 229

[1] The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (04) : 415 - 421

[2] Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) : 527 - 532

[3] Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg) [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) : 4099 - 4103

[4] PREOPERATIVE TREATMENT OF ACROMEGALY WITH LONG-ACTING SOMATOSTATIN ANALOG SMS-201-995 - SHRINKAGE OF INVASIVE PITUITARY MACROADENOMAS AND IMPROVED SURGICAL REMISSION RATE [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (05) : 1040 - 1048

[5] TREATMENT OF RESISTANT ACROMEGALY WITH A LONG-ACTING SOMATOSTATIN ANALOG (SMS 201-995) [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (06) : 856 - 861

[6] DOES TREATMENT OF ACROMEGALY AFFECT LIFE EXPECTANCY [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (01): : 1 - 5

[7] BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X

[8] Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) : 3551 - 3555

[9] RADIOIMMUNOASSAY FOR INSULIN-LIKE GROWTH FACTOR-I - SOLUTIONS TO SOME POTENTIAL PROBLEMS AND PITFALLS [J]. JOURNAL OF ENDOCRINOLOGY, 1991, 128 (03) : 347 - 357

[10] Results of a two-year treatment with slow release lanreotide in acromegaly [J]. HORMONE AND METABOLIC RESEARCH, 2000, 32 (06) : 224 - 229